CTNNB1 and hepatocellular carcinoma: Therefore, by RNA–RNA and RNA–protein interactions, LINC00662 is able to decrease the SAM/SAH balance and de-represses methylated oncogene promoters, activating known HCC oncogenes such as MYC, CTNNB1 and HRAS.